The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 369 results:
Author Title Type [ Year(Desc)]
Filters: Author is Polyzos, Stergios A  [Clear All Filters]
2017
Polyzos, S. A., Bugianesi E., Kountouras J., & Mantzoros C. S. (2017).  Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists.. Metabolism. 66, 64-68.
Kazakos, E. I., Kountouras J., Polyzos S. A., & Deretzi G. (2017).  Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system.. Med Hypotheses. 102, 33-36.
Kountouras, J., Polyzos S. A., Katsinelos P., Kotronis G., & Doulberis M. (2017).  Obesity and the nervous system: more questions.. Lancet Neurol. 16(10), 772-773.
Polyzos, S. A., Makras P., Anastasilakis A. D., Mintziori G., Kita M., Papatheodorou A., et al. (2017).  Periostin and sclerostin levels in juvenile Paget's disease.. Clin Cases Miner Bone Metab. 14(2), 269-271.
Kountouras, C., Polyzos S. A., Stergiopoulos C., Katsinelos P., Tzivras D., Zavos C., et al. (2017).  A potential impact of Helicobacter pylori infection on both obstructive sleep apnea and atrial fibrillation-related stroke.. Sleep Med. 34, 256.
2018
Karras, S. N., Polyzos S. A., Newton D. A., Wagner C. L., Hollis B. W., van den Ouweland J., et al. (2018).  Adiponectin and vitamin D-binding protein are independently associated at birth in both mothers and neonates.. Endocrine. 59(1), 164-174.
Kountouras, J., Polyzos S. A., Doulberis M., Stergiopoulos C., & Katsinelos P. (2018).  Comment on "Therapeutic Application of an Extract of Ameliorates the Development of Allergic Airway Disease".. J Immunol. 200(9), 3027.
Kountouras, J., Doulberis M., Polyzos S. A., Zeglinas C., Vardaka E., Kountouras C., et al. (2018).  Helicobacter pylori Infection and Gastroesophageal Reflux Disease-Barrett's Esophagus-Esophageal Adenocarcinoma Sequence.. Am J Gastroenterol. 113(11), 1723-1724.
Doulberis, M., Kountouras J., Polyzos S. A., Tzivras D., Vardaka E., Kountouras C., et al. (2018).  Impact of Helicobacter pylori and/or Helicobacter pylori-related metabolic syndrome on gastroesophageal reflux disease- Barrett's esophagus- esophageal adenocarcinoma sequence.. Helicobacter. 23(6), e12534.
Polyzos, S. A., Zeglinas C., Artemaki F., Doulberis M., Kazakos E., Katsinelos P., et al. (2018).   infection and esophageal adenocarcinoma: a review and a personal view.. Ann Gastroenterol. 31(1), 8-13.
Polyzos, S. A., Anastasilakis A. D., Efstathiadou Z. A., Makras P., Perakakis N., Kountouras J., et al. (2018).  Irisin in metabolic diseases.. Endocrine. 59(2), 260-274.
Polyzos, S. A., Cundy T., & Mantzoros C. S. (2018).  Juvenile Paget disease.. Metabolism. 80, 15-26.
Polyzos, S. A., & Terpos E. (2018).  Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis.. Endocrine. 62(2), 487-489.
Kountouras, J., Polyzos S. A., & Deretzi G. (2018).  Multiple Bidirectionality Brain-Gut Interactions in Patients With Inflammatory Bowel Disease.. Gastroenterology. 155(5), 1651-1652.
Anastasilakis, A. D., Tournis S., Yavropoulou M. P., Polyzos S. A., & Makras P. (2018).  Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?. Calcif Tissue Int. 103(1), 107-108.
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Makras P., Hawa G., Sonnleitner L., et al. (2018).  Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.. Hormones (Athens). 17(4), 573-579.
Polyzos, S. A., Kountouras J., Anastasiadis S., Doulberis M., & Katsinelos P. (2018).  Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?. Hepatology. 68(1), 389.
Polyzos, S. A., & Mantzoros C. S. (2018).  Outliers of bone metabolic diseases.. Metabolism. 80, 1-4.
Upadhyay, J., Polyzos S. A., Perakakis N., Thakkar B., Paschou S. A., Katsiki N., et al. (2018).  Pharmacotherapy of type 2 diabetes: An update.. Metabolism. 78, 13-42.
Kountouras, J., Doulberis M., Polyzos S. A., Papaefthymiou A., Kapetanakis N., Arapoglou S., et al. (2018).  Potential Impact of Active Helicobacter pylori Infection with or without Concomitant Metabolic Syndrome on Colorectal Cancer Invasion and Mortality.. Isr Med Assoc J. 20(11), 725-726.
Kountouras, J., Polyzos S. A., Katsinelos P., Anastasiadis S., Tzivras D., Doulberis M., et al. (2018).  Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.. Dig Dis Sci. 63(4), 1087-1088.
Boziki, M., Polyzos S. A., Deretzi G., Kazakos E., Katsinelos P., Doulberis M., et al. (2018).  A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration.. Neurochem Int. 113, 137-151.
Kountouras, J., Polyzos S. A., Doulberis M., Zeglinas C., Artemaki F., Vardaka E., et al. (2018).  Potential impact of Helicobacter pylori-related metabolic syndrome on upper and lower gastrointestinal tract oncogenesis.. Metabolism. 87, 18-24.
Doulberis, M., Kotronis G., Thomann R., Polyzos S. A., Boziki M., Gialamprinou D., et al. (2018).  Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far?. Helicobacter. 23(1), 
Polyzos, S. A., & Margioris A. N. (2018).  Sarcopenic obesity.. Hormones (Athens). 17(3), 321-331.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.